OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammationCarlo Marchetti, Charles A. Dinarello, Benjamin J. Swartzwelter et al.|Proceedings of the National Academy of Sciences|2018Cited by 556
Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical TechnologyRoy D. Altman, Clarence L. Young|Drugs|2015Cited by 486
Exercise and education versus saline injections for knee osteoarthritis: a randomised controlled equivalence trialElisabeth Bandak, Marius Henriksen, Roy D. Altman et al.|Annals of the Rheumatic Diseases|2021Cited by 295
Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from GREESÉric Abadie, Jean‐Yves Reginster, Jean-Pierre Devogealer et al.|ORBi (University of Liège)|2005Cited by 0